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soy and dairy rich meals in middle aged men with
metabolic syndrome: a randomised crossover trial
Petra Gran1, Amy E Larsen1, Maxine Bonham1, Aimee L Dordevic1, Thusitha Rupasinghe2, Claudio Silva2,
Amsha Nahid2, Dedreia Tull2, Andrew J Sinclair3, Cameron J Mitchell4 and David Cameron-Smith1,4*Abstract
Background: The mammalian target of rapamycin (mTOR) pathway is the primary regulator of muscle protein
synthesis. Metabolic syndrome (MetS) is characterized by central obesity and insulin resistance; little is known about
how MetS affects the sensitivity of the mTOR pathway to feeding.
Methods: The responsiveness of mTOR pathway targets such as p706Sk to a high protein meal containing either
dairy or soy foods was investigated in healthy insulin sensitive middle-aged men and those presenting with metabolic
syndrome (MetS). Twenty male subjects (10 healthy controls, 10 MetS) participated in a single-blinded randomized
cross-over study. In a random sequence, subjects ingested energy-matched breakfasts composed predominately of
either dairy-protein or soy-protein foods. Skeletal muscle biopsies were collected in the fasted state and at 2 and 4 h
post-meal ingestion for the analysis of mTOR- and insulin-signalling kinase activation.
Results: Phosphorylated Akt and Insulin receptor substrate 1 (IRS1) increased during the postabsorptive period with no
difference between groups. mTOR (Ser448) and ribosomal protein S6 phosphorylation increased 2 h following dairy
meal consumption only. p70S6K (Thr389) phosphorylation was increased after feeding only in the control subjects and
not in the MetS group.
Conclusions: These data demonstrate that the consumption of a dairy-protein rich but not a soy-protein rich breakfast
activates the phosphorylation of mTOR and ribosomal protein S6, required for protein synthesis in human skeletal
muscle. Unlike healthy controls, subjects with MetS did not increase muscle p70S6K(Thr389) phosphorylation in
response to a mixed meal.
Trial registration: This trial was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) as
ACTRN12610000562077.Introduction
Skeletal muscle is the most abundant tissue in the
human body, aside from its primary role in locomotion
it is also the primary site of oxidative metabolism,
insulin-stimulated glucose uptake [1] and amino acid
uptake [2]. Muscle size is regulated by the balance be-
tween muscle protein synthesis (MPS) and muscle protein* Correspondence: d.cameron-smith@auckland.ac.nz
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unless otherwise stated.breakdown (MPB) [3]. In the fasted state MPS is sup-
pressed and MPB is elevated such that the muscle is in
a net catabolic state [4]. In young healthy individuals
the ingestion of a protein containing meal results in an
elevation in MPS and a suppression of MPB resulting
in a net anabolic state [4]. In healthy young individuals
postabsorptive catabolism and postprandial anabolism
are equal in the long term and muscle size is maintained
[3]. MPS appears to be much more tightly regulated than
MPB [5] and is primarily regulated though the mamma-
lian target of the rapamycin (mTOR) pathway which is
sensitive to the effects of growth factors such as insulin,d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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acid (BCAA) leucine has been shown to be the primary
nutrient regulator of the mTOR pathway [7].
The consumption of intact protein or an amino acid
mixture containing leucine results in a robust phosphor-
ylation of p70S6 kinase (p70S6K), a downstream target
of the mTOR pathway [8-10]. p70S6K phosphorylation
leads to increases in the initiation of protein translation
and ultimately MPS. Short term physical inactivity appears
to lead to a decreased MPS response to protein feeding;
however, changes in the response of the mTOR pathway
are less clear [11-13]. In many but not all studies, old
age is associated with an ‘anabolic resistance’ to pro-
tein feeding where MPS is not elevated in response to
feeding in the elderly. This anabolic resistance appears
to be mediated through decreased sensitivity of the
mTOR pathway to feeding [9,14]. It is unclear if ageing
per se is the cause of impaired anabolic signalling or if
a decline in physical activity and a different metabolic
phenotype are the underlying causes of the observed
anabolic signalling deficits.
Many studies have examined the effects of free
amino acid or intact protein ingestion on MPS and
mTOR signaling [9,15].
These studies have shown that proteins high in the
BCAA leucine result in greater mTOR activation com-
pared with proteins containing less leucine [8,15-17].
Dairy and soy food are sources of dietary protein; be-
cause of its greater leucine content, milk protein appears
to results in a greater MPS response than soy protein, at
least after resistance exercise [18]. There have been a
few recent studies which have examined MPS and
mTOR pathway response to the ingestion of mixed
macronutrient beverages; however, there is very little re-
search on the ingestion of true mixed meal on activation
of the mTOR pathway [15,19]. There is evidence that
the addition of fat, carbohydrate and fiber to protein
may slow the appearance of amino acids in the blood
and thus blunt the anabolic signalling response [20-22].
There is also evidence that consuming solid food rather
than a liquid supplement results in a slower rate of ap-
pearance of amino acids in the blood [22].
Metabolic syndrome (MetS) is a characterized by a
cluster of conditions which include central obesity,
dyslipidemia, high blood pressure and insulin resist-
ance [23]. There has been little research on MetS and
protein metabolism; however, older type 2 diabetics
display lower muscle strength, mass, and quality com-
pared to age matched controls [24]. Type 2 diabetics
also display an insulin resistance of protein metabolism
at the whole body level [25]. However, they are able to
normally activate some members of the mTOR pathway
in muscle during a hyperinsulinaemic hyperaminoacidae-
mic clamp [26]. Little is known about the muscle anabolicresponse of those with MetS under more physiological
conditions such as mixed meal consumption.
Therefore the objectives of the current study were
three fold. Firstly, to determine whether ingestion of a
single breakfast meal results in the activation of the
mTOR signalling pathway in middle aged men. Secondly,
to examine whether meals differing in amino acid com-
position, yet matched for total energy and macronutrient
composition, result in altered mTOR signalling. Lastly,
to investigate if middle aged men with MetS display a
resistance of anabolic signalling to mixed meal ingestion
compared with healthy controls.
Methods
Subjects
A total of 20 men (n = 10 healthy controls, n = 10 MetS)
aged between 40–60 years were recruited from newspaper,
poster, and flyer advertisements to participate. Subjects
were classified as having MetS based on the International
Diabetes Federation criteria [27]. They had to present
with abdominal obesity (waist circumference ≥ 94 cm)
and two of the following factors: raised serum triglyc-
erides (≥1.7 mmol/l), reduced serum HDL cholesterol
(<1.03 mmol/l), impaired fasting glycaemia (fasting
plasma glucose ≥5.6 mmol/l) or raised blood pressure
(systolic blood pressure ≥130 mmHg or diastolic blood
pressure ≥85 mmHg). A cohort of age and height matched
healthy controls, without MetS were also included. Sub-
jects were excluded if they showed evidence of acute or
chronic inflammatory disease, infectious diseases, cancer,
and/or known alcohol consumption (>20 g per day). Sub-
jects with fasting glucose concentrations indicative of
T2DM were also excluded along with people on diabetic
medications. All experimental procedures were performed
in accordance with the Helsinki declaration of 1975 as re-
vised in 1983 and were formally approved by the Deakin
University Human Research Ethics Committee (EC-120,
2008). Informed written consent was obtained from each
subject before participation in the study and after the na-
ture, purpose, and risks of the study were explained and
subjects informed of their right to withdraw from the trial
at any stage of the investigation.
Experimental design
A controlled crossover single meal study was conducted
to examine the postprandial effects to either a dairy or
soy meal, with at least four weeks wash out between the
study days. Subjects were instructed to abstain from alco-
hol, caffeine and tobacco on the day proceeding the trial
day. On the morning of the trial, subjects presented to the
Deakin University clinical laboratory in a fasted state.
Upon arrival, they had their height, weight and blood
pressure measured. A cannula was inserted in the antecu-
bital vein and a fasting blood sample was collected. Blood
Table 2 Amino acid composition of the test meals
Amino Acid Soy Dairy
mg/g (%)
Histidine 2.1 2.3
Serine 6.7 6.8
Arginine 5.2 2.8
Glycine 7.2 3.8
Aspartic acid 9.5 6.4
Glutamic acid 21.5 21.6
Threonine 4.0 4.1
Alanine 5.9 4.5
Proline 8.1 11.8
Lysine 4.8 6.2
Tyrosine 2.1 3.0
Methionine 1.1 2.2
Valine 5.3 6.6
Isoleucine 4.5 4.7
Leucine 7.8 9.1
Phenylalanine 4.3 4.0
Total BCAA 17.6 20.4
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240 min following the test meal for plasma amino acid
analysis. Following 30 min of supine resting, a muscle
sample was collected from the vastus lateralis under local
anesthesia (Xylocaine 1%) by percutaneous needle biopsy
technique [28] modified to include suction [29]. Muscle
tissue from each biopsy was immediately frozen and
stored in liquid nitrogen for later analysis. Following this,
subjects were required to consume a high fat dairy or high
fat soy meal within approximately 15 min. The details of
the study design and meal have been previously reported
[30]. Further muscle samples were collected at 2 h and 4 h
post meal ingestion with serial biopsy samples collected at
least 2 cm from previous biopsy sites.
Test meals
Subjects were randomly assigned to consume either a
breakfast meal comprised of dairy-derived protein or
void of dairy-derived proteins (replaced with the same
level of soy based protein). The interval between the
two test meals was at least four weeks. To prevent pos-
sible differences between subjects at baseline from their
previous meal the night prior to the study day, subjects
were provided with a controlled meal for dinner. The
meal consisted of a pre-packaged lasagna and fruit yogurt
providing a total of 2462 kJ as 20% fat, 18% protein and
62% carbohydrates. Subjects were asked to eat only the
provided food and nothing else. The test breakfast meals
consisted of cheese, butter, and full cream milk with white
bread toast (dairy breakfast) and the second meal con-
tained soy cheese analogue, soy beverage, a soy spread,
and white bread toast and contained the same amount of
protein (31 g) with similar carbohydrate content (Table 1).
As the test meals contained different sources of protein,
the amino acid composition also differed (refer to Table 2).
Subjects were asked to consume the entire breakfast meal
within 15 min.
Quantitative amino acid analyses of test meals
Test meals were homogenized and underwent liquid
hydrolysis in 6 M HCl at 110°C for 24 h. FollowingTable 1 Energy content and macronutrient composition of th
Meal Composition Amount Total energy (kJ)
Soy Margarine 20 g 3276
Full fat soy milk 300 mL
Soy cheese 100 g
Bread (white) 50 g
Dairy Butter 23 g 3120
Full cream milk 300 mL
Cheese 70 g
Bread (white) 50 ghydrolysis, amino acid derivation was conducted using
AccQ-Tag reagents as per manufacturer’s instruc-
tions. Liquid chromatographic analysis was performed
on a Waters Acquity UPLC system, equipped with
a binary solvent manager, an autosampler, a column
heater, a PDA detector, and interfaced to a tandem
quadrupole detector at the Australian Proteome Ana-
lysis Facility (APAF; Macquarie University, New South
Wales, Australia) [31].
Anthropometric measurements
Weight, height and waist circumference were measured
at baseline and upon arrival to the clinical laboratory
following an overnight fast on test days. Blood pressure
was measured on three occasions using a mercury
sphygmomanometer.e high fat meals
Protein (g) Fat (g) Carbohydrate (g) Sodium (mg)
31 54 48 1297
31 54 37 951
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Venous blood samples were drawn at fasting, 30 min,
60 min, 180 min, and 240 min after consumption of
the meal using EDTA tubes. EDTA blood samples were
centrifuged at 3000 rpm for 15 min and 300 μL of sepa-
rated plasma removed for subsequent amino acid analysis.
Blood samples were also collected in serum tubes, centri-
fuged at 3000 rpm for 15 min, stood for 30 min at room
temperature, and were then supplied to Cabrini Pathology
(Cabrini Health, Victoria, Australia) for assessment of in-
sulin and glucose. To estimate insulin resistance, HOMA
index was calculated by the formula: HOMA = (fasting
plasma insulin in μU/mL × fasting plasma glucose in
mM)/22.5 [32,33].
Plasma amino acids
Quantification of plasma amino acids was carried out by
reverse-phase high-performance liquid chromatography
(HPLC) with pre-column derivitisation of plasma sam-
ples with purified 6-aminoquinolyl-N-hydroxysuccini-
midyl carbamate (AQC; School of Botany, University
of Melbourne, Victoria, Australia) followed by reverse-
phase HPLC [31]. Briefly, 50 μL of plasma was incubated
with 100 μL of chilled acetonitrile (ACN) to precipitate
plasma proteins. Samples were briefly vortexed and centri-
fuged for 10 min at 0°C before 10 μL of the resulting
supernatant was aliquoted into an HPLC vial with glass
insert for derivitisation. Seventy microlitres of borate
buffer was then added to each sample and subsequently
mixed prior to the addition of 20 μL of 3 mg/mL (w/v)
AQC. Derivitisation reaction occurred with heating at
55°C for 10 min with gentle agitation at 750 rpm. Separ-
ation of samples was achieved using an Agilent 1200 Series
LC system with a Binary SL pump (Agilent Technologies,
California, USA). AQC derivatives were subsequently
detected using an Agilent 6460 Triple Quad LC/MS
with dynamic MRM detection. All samples were ana-
lysed using Agilent Masshunter Quantitative Analysis
software, version B.03.02, 2008 (Agilent Technologies).
Plasma amino acid concentrations were determined by
measuring the absolute area under the curve relative to
a standard curve generated using preparations of an in-
ternal standard (2-aminobutyric acid; data not shown).
All samples from an individual subject were analysed
within the same assay in a randomised order.
Immunoblotting
Approximately 30 mg of muscle was homogenized, in
lysis buffer (pH 7.0) containing 20 mM Tris–HCl, 5 mM
EDTA, 10 mM Na-pyrophosphate, 100 mM NaF, 2 mM
Na3VO4, 1% Igepal, 10 g/mL Aprotinin, 10 g/mL
Leupeptin, 3 mM Benzamidine and 1 mM PMSF.
The homogenate was rotated for 1 h at 4°C and subse-
quently centrifuged at 14,000 rpm for 15 min with theresulting supernatant collected into a fresh tube. Protein
concentrations were determined using a BCA Protein
Assay (Pierce, Thermo Scientific, New South Wales,
Australia) with bovine serum albumin (BSA) as a stand-
ard. Muscle homogenate was then denatured in loading
buffer containing dithiothreitol (DTT) and separated by
sodium dodecyl sulphate-polyacrylamide gel electrophor-
esis (SDS-PAGE). Proteins were then transferred onto
nitrocellulose membrane and blocked at room temperature
using 5% BSA (Sigma-Aldrich) in tris buffered saline with
0.1% (v/v) Tween-20 (TBST; Sigma-Aldrich). Membranes
were incubated overnight with antibodies in 5% BSA at
4°C. Expression of signalling kinases was determined
using primary antibodies (1:1,000) specific for IRS1Tyr612,
AktSer473, mTORSer2448, p70S6KThr389, and ribosomal
S6Ser240/244 (Cell Signaling). Membranes were subse-
quently washed and then incubated with anti-rabbit HRP-
conjugated secondary antibody (1:1000; Calbiochem) for
1 h at room temperature. Following this, membranes were
washed repeatedly as before, and proteins visualized using
enhanced chemiluminescence (Perkin-Elmer, Queensland,
Australia) on a Kodak 4000MM Image Station (Kodak,
New York, USA) using a CCD camera. Membranes were
stripped using Restore Western Blot Stripping buffer™
(Quantum Scientific, Victoria, Australia) and then subse-
quently reprobed for total mTOR, total p70S6K, and total
eIF4G proteins to verify the relative amount of analyzed
proteins. Band density was quantified using Kodak im-
aging software version 4.5.0 (Kodak); each phosphorylated
protein was normalized to its respective total protein.
Statistical analysis
Statistical analysis was performed using SPSS version
20 for Windows (SPSS Inc.). Data are reported as
means ± standard error of the mean (SEM). Paired Students
t-test with Bonferroni adjustment was used to determine
significance of between group differences at baseline.
A two-way analysis of variance (ANOVA) with group
(control, MetS) and meal (dairy, soy) as factors was used
to test for BCAA area under the curve (AUC) difference.
Differences in all other variables were tested using a
three-way ANOVA with group (control, MetS) and meal
(dairy, soy) as between subject factors and time as a within
subject factor. The Holm-Sidak post hoc method was used
to compare pair wise differences when interactions were
present. A probability level of <0.05 was adopted through-
out to determine statistical significance.
Results
Amino acid composition of test meals
There were slight differences in the relative abundances
of each amino acid between the soy and dairy meal
(Table 2). Leucine concentration was 1.2-fold higher in
the dairy meal compared to the soy meal. Similarly, the
Figure 1 Postprandial time course of plasma insulin and glucose.
Insulin (μU/mL) (A) and glucose (mg/dL) (B) concentrations were
assessed in plasma collected from healthy control and metabolic
syndrome subjects following consumption of a high fat soy or dairy
breakfast. Healthy control subjects are represented with solid lines and
closed squares (■) for the dairy meal and closed circles (●) for the soy
meal. Metabolic syndrome (MetS) subjects are represented with
dashed lines and open squares (□) for the dairy meal and open circles
(○) for the soy meal. The graphs represent mean values ± SEM; n = 10
per group. * = Significantly different than baseline within the Metabolic
syndrome subjects irrespective of meal P < 0.05. # = significantly
different from baseline within healthy control subjects irrespective of
meal P < 0.05. † = Significant difference between subjects with
metabolic syndrome and healthy control irrespective of meal P < 0.05.
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greater than the soy meal yet matched for total protein.
Plasma concentrations of insulin and glucose
Baseline plasma insulin concentrations were not different
between the alternate meal days within each group. Glu-
cose concentration (Figure 1A) did not differ betweenTable 3 Baseline characteristics and physiological measures1
Healthy n = 10
Age (years) 51.2 ± 1.4
Weight (kg) 83.1 ± 1.9
BMI (kg/m2) 26.6 ± 0.8
Waist circumference (cm) 93.6 ± 2.3
HOMA index 1.4 ± 0.1
Fasting insulin (μUI/mL) 6.1 ± 0.5
Fasting glucose (mg/dL) 5.1 ± 0.1
1All results presented as means ± SEM.groups at baseline; however, there was a group X time
interaction (P < 0.001) such that plasma glucose was ele-
vated above baseline in the MetS group at 60 min after
the meal and was below baseline at the same time point in
the healthy control group irrespective of meal. Fasting
blood insulin concentrations were significantly greater in
the MetS subjects compared with their healthy control
counterparts (9.6 ± 0.1 and 6.1 ± 0.5 respectively; P < 0.01;
Table 3). There was a group main effect (P = 0.005) and
group X time (P = 0.027) interaction in plasma insulin
concentration such that insulin concentration was greater
in the MetS subjects at every time point with the excep-
tion of 120 min; the difference was largest at 60 min after
consumption of the meal (Figure 1B). Furthermore, sub-
jects presenting with MetS appeared to be less insulin
sensitive (i.e. more insulin resistant) than the healthy
control subjects. The homeostasis model of assessment
(HOMA) index was 1.8-fold higher in MetS subjects
compared with the healthy controls (P < 0.01; Table 3).
There were no meal effects (glucose: P = 0.49, insulin:
P = 0.066) or meal X time interactions (glucose: P = 0.49,
insulin: P = 0.51).Plasma concentrations of amino acids
In order to elucidate differences in the plasma amino
acid profile after consumption of a single mixed meal,
plasma amino acid concentrations were measured at 0, 30,
60, 180, and 240 min in both healthy control and MetS
subjects. Table 4 (control) and Table 5 (MetS) show the
plasma concentrations over time of all the individual
amino acids which could be resolved with the HPLC.
Total plasma amino acid concentration did not differ
between groups but did differ between meals (meal X
time, P = 0.047); greater total amino acid concentration
was observed 180 min after the dairy meal compared
with the soy meal. Figure 2A shows the plasma BCAA
(leucine, isoleucine, valine) response to the dairy and
soy meals in control and MetS subjects. BCAAs followed
the same pattern as total amino acids such that there was
a greater BCAA concentration following the dairy meal
at 180 min post ingestion compared to the soy mealMetabolic syndrome n = 10 P value
53.1 ± 1.5 0.359
102.2 ± 5.5 0.004
33.5 ± 1.9 0.003
111.9 ± 3.8 0.000
2.5 ± 0.3 0.007
9.6 ± 1.0 0.005
5.9 ± 0.4 0.101
Table 4 Time course changes in plasma concentrations of selected amino acids in healthy controls1
Soy (n = 10) Dairy (n = 10)
Time (min)
0 30 60 180 240 0 30 60 180 240
μmol/L
Arginine 11.0 ± 1.0 14.6 ± 2.3 13.0 ± 1.1 10.7 ± 0.8 10.3 ± 1.4 9.6 ± 0.9 9.3 ± 0.5 10.7 ± 0.9 11.3 ± 1.5 8.5 ± 0.8*
Asparagine 7.9 ± 1.0 9.8 ± 0.6 9.9 ± 0.5 7.5 ± 0.4 6.7 ± 0.6 7.0 ± 0.5 7.1 ± 0.5 8.4 ± 1.0 8.5 ± 0.8 6.5 ± 0.5
Serine 15.8 ± 2.0 17.1 ± 1.5 16.9 ± 1.1 14.1 ± 0.8 11.0 ± 0.5 14.1 ± 1.5 13.4 ± 1.2 16.4 ± 1.7 16.4 ± 1.4 13.8 ± 0.9
Glutamine 95.3 ± 2.4 101.7 ± 3.9 108.2 ± 2.2** 105.0 ± 6.4 96.9 ± 4.4 104.9 ± 6.2 96.7 ± 3.7 111.0 ± 6.8 121.8 ± 9.1 105.0 ± 5.4
Taurine 10.2 ± 0.8 9.9 ± 1.0 10.2 ± 1.2 9.3 ± 1.3 10.5 ± 1.2 10.8 ± 1.1 7.6 ± 0.4** 8.5 ± 1.0 9.8 ± 0.9 9.6 ± 0.8
Glycine 43.4 ± 2.1 48.0 ± 3.0 47.5 ± 2.0 46.5 ± 4.4 37.6 ± 2.9 47.5 ± 2.7 37.6 ± 2.3* 42.3 ± 3.2 43.8 ± 3.4 37.2 ± 1.6**
Proline 73.3 ± 4.7 86.1 ± 4.7* 93.6 ± 4.8** 82.3 ± 4.2 75.5 ± 3.9 69.6 ± 3.5 81.5 ± 3.7 91.0 ± 4.2* 112.6 ± 7.6** 92.5 ± 3.3**
Lysine 20.3 ± 2.5 21.7 ± 2.8 20.6 ± 1.5 18.5 ± 2.5 18.1 ± 2.5 17.4 ± 2.2 18.1 ± 1.6 22.3 ± 1.9 21.8 ± 3.2 17.5 ± 2.2
Valine 92.5 ± 7.0 98.0 ± 4.5* 102.6 ± 4.4* 91.4 ± 4.4 84.6 ± 5.2 89.1 ± 6.0 89.9 ± 5.0* 110.3 ± 7.5* 119.3 ± 6.3** 103.4 ± 5.5*
Isoleucine 35.0 ± 3.1 46.5 ± 3.3 47.3 ± 2.9* 39.4 ± 2.5 36.9 ± 2.5 31.3 ± 2.5 39.0 ± 2.6** 46.7 ± 3.5* 48.1 ± 3.0* 36.6 ± 1.8
Leucine 80.3 ± 6.2 92.2 ± 5.0 91.9 ± 4.5 74.8 ± 3.7 68.4 ± 4.2 72.0 ± 4.9 84.6 ± 4.8** 101.0 ± 7.3 103.7 ± 6.0* 83.9 ± 5.3
∑BCAA 206.2 ± 17.3 236.7 ± 16.3 241.7 ± 16.9** 205.5 ± 15.3 190.0 ± 14.0 192.4 ± 17.2 228.8 ± 17.1 257.9 ± 19.8* 265.4 ± 20.4* 226.1 ± 19.1*
∑Total AA2 545.5 ± 52.9 577.0 ± 28.9 597.3 ± 20.6 526.5 ± 25.8 486.6 ± 28.8 505.8 ± 29.0 527.5 ± 28.9 597.5 ± 37.1* 658.2 ± 38.7** 540.5 ± 24.0*
1Means which are statistically different from baseline (0 min) for each meal are indicated by: * P < 0.05, ** P < 0.01.
2Total AA: sum of measurable amino acids.
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Table 5 Time course changes in plasma concentrations of selected amino acids in subjects with metabolic syndrome1
Soy (n = 10) Dairy (n = 10)
Time (min)
0 30 60 180 240 0 30 60 180 240
μmol/L
Arginine 8.7 ± 0.7 11.3 ± 0.8** 11.9 ± 1.0** 9.3 ± 0.9 8.5 ± 0.8 8.6 ± 0.4 9.6 ± 0.5 10.5 ± 0.7* 8.9 ± 0.6 7.7 ± 0.4
Asparagine 6.3 ± 0.8 8.7 ± 0.8** 8.4 ± 0.8** 6.4 ± 0.4 6.3 ± 0.5 6.3 ± 0.4 7.2 ± 0.5 8.0 ± 0.4** 6.6 ± 0.4 5.9 ± 0.2
Serine 12.9 ± 1.7 13.3 ± 0.8 15.2 ± 1.5 12.3 ± 1.6 11.5 ± 1.1 13.3 ± 1.4 15.4 ± 1.4 15.8 ± 1.4** 13.8 ± 1.4 12.7 ± 1.4
Glutamine 99.5 ± 7.0 90.9 ± 7.4* 95.6 ± 6.7 89.6 ± 4.1* 94.3 ± 4.8 99.7 ± 6.4 95.7 ± 6.5 103.1 ± 4.7 102.7 ± 6.5 103.4 ± 7.0
Taurine 8.6 ± 0.8 7.7 ± 0.5 8.0 ± 0.6 8.5 ± 0.6 8.6 ± 0.5 8.8 ± 0.5 7.4 ± 0.3* 8.3 ± 0.3 8.3 ± 0.5 8.2 ± 0.4
Glycine 36.7 ± 3.6 36.6 ± 3.4 37.4 ± 3.5 33.4 ± 2.5* 37.1 ± 4.8* 40.2 ± 3.8 35.8 ± 2.2 38.5 ± 2.5 34.5 ± 2.5** 32.9 ± 2.4*
Proline 65.8 ± 3.8 79.6 ± 5.5** 86.7 ± 7.8** 74.6 ± 4.6** 74.4 ± 6.3 68.5 ± 3.8 83.2 ± 5.0* 101.6 ± 5.8** 99.4 ± 5.9** 88.1 ± 5.9**
Lysine 16.6 ± 1.7 19.6 ± 2.5 19.4 ± 2.4 15.6 ± 2.3 16.8 ± 2.0 15.1 ± 1.1 20.5 ± 2.4* 18.6 ± 1.6** 19.8 ± 2.9 18.0 ± 2.1
Valine 99.0 ± 7.2 108.0 ± 6.5** 109.4 ± 7.6* 95.3 ± 6.3 93.2 ± 4.4 88.9 ± 4.7 101.3 ± 4.9* 112.2 ± 4.0** 111.1 ± 6.6** 103.4 ± 5.1**
Isoleucine 35.4 ± 2.6 47.6 ± 2.6** 47.8 ± 3.1** 38.4 ± 2.4 36.5 ± 1.7 31.7 ± 2.1 44.4 ± 2.8** 47.7 ± 2.2** 43.0 ± 3.2** 38.2 ± 3.1*
Leucine 78.2 ± 4.9 98.3 ± 4.4** 93.7 ± 4.8** 72.2 ± 3.6* 68.8 ± 2.6* 70.4 ± 4.9 100.6 ± 4.3** 103.5 ± 2.2** 90.4 ± 5.8** 83.8 ± 4.8*
∑BCAA 212.6 ± 18.7 253.9 ± 18.7* 251.0 ± 18.5* 205.9 ± 16.5 242.4 ± 21.1 196.2 ± 17.8 243.1 ± 18.4 264.8 ± 20.4* 247.6 ± 20.4* 224.0 ± 19.2*
∑Total AA2 538.0 ± 62.8 585.7 ± 56.9** 605.4 ± 69.1** 515.6 ± 51.1 527.2 ± 125.8 489.0 ± 24.3 546.5 ± 24.7 602.4 ± 21.5** 569.7 ± 31.1** 527.2 ± 32.5
1Means which are statistically different from baseline (0 min) for each meal are indicated by; * P < 0.05, ** P < 0.01.
2Total AA: sum of measurable amino acids.
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Figure 2 Plasma BCAA response to mixed-meal ingestion. Plasma concentration of the three branched chain amino acids (BCAA) leucine,
isoleucine and valine were measured in healthy control and metabolic syndrome subjects following consumption of a high fat soy or dairy
breakfast. A) Time course of BCAA concentrations; healthy control subjects are represented with solid lines and closed squares (■) for the dairy
meal and closed circles (●) for the soy meal. Metabolic syndrome (MetS) subjects are represented with dashed lines and open squares (□) for the
dairy meal and open circles (○) for the soy meal. B) Area under the curve (AUC); open bars represent soy and closed bars represents dairy meals.
The graphs represent mean values ± SEM; n = 10 per group. Ψ = significantly different from baseline within the soy condition irrespective of group
P < 0.05. Φ = significantly different from baseline within the dairy condition irrespective of group P < 0.05. ‡ = Significant difference between the
dairy and soy conditions irrespective of group P < 0.05.
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http://www.nutritionandmetabolism.com/content/11/1/46irrespective of group (meal X time, P = 0.047). A greater
AUC for BCAAs was observed following the dairy meal
compared with the soy meal irrespective of subject group
(P < 0.001; Figure 2B).
Protein phosphorylation
In order to delineate whether individuals exhibiting
metabolic dysregulation have impaired insulin signalling,
the phosphorylation response of IRS1 to both a mixed
dairy and soy meal was investigated. There were no group,
or meal effects or interactions however, a main effect for
time was observed (P = 0.008). Collapsed across all groups
and conditions IRS1 phosphorylation on Tyr612 wasincreased ~2-fold at 2 h and ~1.6-fold at 4 h post meal
consumption (Figure 3A). There was a trend (P = 0.07) for
less phosphorylation in the healthy control group 2 h post
consumption of the soy meal compared with the other
conditions.
Given that mTOR-mediated anabolic signaling may also
occur via insulin stimulation, activation of the upstream
mediator, Akt, was examined (Figure 3B). Similarly to IRS1
there were no significant group or meal effects or interac-
tions; however, there was a main effect for time (P = 0.006).
Irrespective of group or meal, Akt protein phosphorylation
on Ser473 was increased at 2 h post meal consumption and
to a lesser extent at 4 h post meal consumption.
Figure 3 Activation of IRS1and Akt during the postprandial period in human skeletal muscle. Phosphorylation is normalized to the total
content of each protein and expressed in arbitrary units. IRS (Tyr612) (A) and Akt (Ser473) (B) phosphorylation are shown of healthy control and
metabolic syndrome (MetS) subjects following consumption of a high fat soy or dairy breakfast. The graphs represent mean values ± SEM; n = 10
per group. ** = Significant main effect for time, different than baseline and 4 h irrespective of group or meal P < 0.05. * = Significant main effect
for time, different than baseline irrespective of group or meal. † = Significant difference between subjects with metabolic syndrome and healthy
control subjects irrespective of meal P < 0.05.
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http://www.nutritionandmetabolism.com/content/11/1/46In order to determine whether dairy-derived proteins
can elicit greater mTOR activation in human skeletal
muscle tissue, mTOR phosphorylation was evaluated. A
main effect for time (P = 0.005) was observed as well as
a meal effect (P = 0.05) and a trend towards a meal X
time interaction (P = 0.072). Because the fold change in
each group and condition was equalled at rest the group
effect was indicative of an interaction even though the
meal X time term in the ANOVA was only a trend.
Post hoc analysis revealed in elevation in mTOR
Ser2448 phosphorylation at 2 h only following the
dairy meal irrespective of group (Figure 4A). No group
effect (P = 0.81) or group X time interaction (P = 0.75)
was observed.
To confirm that greater mTOR activation leads to in-
creased protein translation, activation of the downstream
kinase, p70S6K, was measured (Figure 4B). A time X
group interaction (P = 0.046) revealed that p70S6K phos-
phorylation on Thr389 was increased only in the healthy
controls and not in the MetS group. No meal (P = 0.28) or
meal X time interactions were observed (P = 0.36). This
finding indicates an anabolic resistance to mixed meal
consumption in the MetS group compared to controls.Expression of phosphorylated ribosomal protein S6
kinase on Ser240/244 was elevated 2 h and 4 h following
consumption of the dairy meal in both the MetS and
control groups (meal X time interaction, P = 0.013). There
was no elevation in ribosomal protein S6 kinase phos-
phorylation following the consumption of the soy meal.
There was no group (P = 0.39) effect or group X time
interaction (P = 0.54). Representative western blots for
each of the tested proteins are shown in Figure 5.
Discussion
The primary finding of the present study is that obese
middle-aged men with metabolic syndrome but without
overt type 2 diabetes show impairment in anabolic signal-
ling following the consumption of ~30 g of protein in the
context of a mixed-meal. This impairment was evidenced
by a lack of p70S6K activation at 2 and 4 hours after
mixed-meal consumption compared to healthy control
subjects. No differences between subjects with MetS and
healthy controls were observed in the activation of riboso-
mal protein S6 which is also a downstream target within
the mTOR pathway. S6 activation and mTOR Ser2448 ac-
tivation were greater following the ingestion of the dairy
Figure 4 Activation of mTOR, p70S6K and S6 during the postprandial period in human skeletal muscle. Phosphorylation is normalised to
the total content of each protein and expressed in arbitrary units. mTOR (Ser2448) (A), p70S6K (Thr389) (B), and (C) rps6 (Ser240/244) phosphorylation are
shown of healthy control and metabolic syndrome (MetS) subjects following consumption of a high fat soy or dairy breakfast. The graphs represent mean
values ± SEM; n= 10 per group. ‡= Significant difference between the dairy and soy conditions irrespective of group P< 0.05. * = Significant main effect
for time, different than baseline irrespective of group or meal P< 0.05.
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http://www.nutritionandmetabolism.com/content/11/1/46meal compared with the soy meal suggesting that the
more sustained levels of BCAAs in the plasma following
consumption of the dairy meal may result in a greater
anabolic stimulus than the soy meal.
We report that when matched for total protein, fat,
and similar in carbohydrate content dairy and soy based
meal result in very similar blood glucose and insulin
responses but that the dairy meal results in a more sus-
tained BCAA concentration in the plasma and a largerBCAA AUC. The more sustained BCAA response is
likely a result of the greater BCAA content in dairy meal
and a slower release from the gut. Despite not being
overtly diabetic the MetS group displayed a much larger
insulin response and slightly greater glucose response to
both meals compared with the control subjects. This in
combination with the difference in HOMA at baseline
indicates large divergence in insulin sensitivity be-
tween groups. Notwithstanding the observed differences
Figure 5 Representative Western blots. Example blots of protein extracted from samples of healthy control (left) and metabolic syndrome
(right) subjects taken at baseline (0), 2 h, and 4 h post-ingestion of a mixed soy or dairy meal. Blots are shown for total insulin receptor (IRS1) and
phosphorylation at Tyr616, total Akt and phosphorylation at Ser473, total mTOR and phosphorylation at Ser2448, total p70S6K and phosphoryl-
ation at Thr380 and total S6 and phosphorylation at Ser240/244.
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http://www.nutritionandmetabolism.com/content/11/1/46in insulin sensitivity between MetS and controls, there
were no significant differences in IRS1 or Akt phosphoryl-
ation after the consumption of either meal in either
controls or MetS. Previous work has shown that type 2
diabetics display an insulin resistance to amino acid in-
fusion [25]; however, in this study a mixed-meal does
not appear to impair anabolic insulin signalling in the
muscle of middle age men with MetS. It seems unlikely
that insulin insensitivity is responsible for the observed
downstream signalling deficit in the MetS group. How-
ever, it is possible that the addition of more subjects
would have resulted in significant differences in Akt or
IRS1 phosphorylation between controls and MetS. At
2 h post meal Akt phosphorylation was ~ two fold
higher and IRS1 was ~ two fold lower in the controls
compared to the MetS.
P70S6K is the primary readout used to assess the
activity of the mTOR pathway [6,34]; the lack of change in
P70S6K phosphorylation after mixed-meal consumption
in men with MetS is similar to the anabolic resistance
induced by periods of inactivity [11,12] and is observed
in older adults [9,14]. Although protein synthesis was
not directly measured in this study signalling deficits
have been shown to underlie ageing induced anabolic
resistance [9]. In the current study we did not measure
physical activity or physical fitness; however, it is likely
that the MetS subjects were less physically active and fitthan the controls [35]. Recent work in obese older
adults has shown an insensitivity of MPS to a mixed
macronutrient beverage ingestion which is transiently
reversed by energy deficit and weight loss; however, the
anabolic sensitivity was lost once subjects returned to
their normal unsupervised diet despite maintained weight
loss [36]. A possible mechanism which could underlie this
anabolic resistance may be higher baseline resting
phosphorylation of mTOR pathway components such
as p70S6K [37]. This could be due to a constant nutri-
ent excess in obese subjects [38,39]. Other studies have
shown higher levels of BCAAs in the obese even under
fasting conditions [40]; however, we did not replicate
this finding. Katta et al. (2009) showed diminished
activation of Akt/mTOR kinases, including p70S6K,
within the skeletal muscle of obese compared to lean
rats following a contractile stimulus [41]. Conversely,
similar rates of protein synthesis were observed in the
skeletal muscle of T2DM and control subjects following
administration of a high-energy clamp [42]. However,
Nilsson et al. (2010) have demonstrated that while
cytosolic and myofibrillar proteins exhibit similar rates
of protein synthesis in obese and lean rats, synthesis of
mitochondrial proteins is blunted in the obese group
[43]. Collectively with the aforementioned studies, the
current data suggests that perhaps metabolic disease re-
sults in a divergent anabolic response in skeletal muscle
Gran et al. Nutrition & Metabolism 2014, 11:46 Page 12 of 14
http://www.nutritionandmetabolism.com/content/11/1/46which is influenced by both metabolic irregularities and
nutritional stimuli.
The greater S6 activation seen after the consumption
of the dairy meal compared with the soy meal suggests
that the greater BCAA content of dairy meal was suffi-
cient to induce greater S6 activation. MetS did not affect
S6 activation suggesting that S6 and p70S6K are regulated
differently. At first it may seem surprising that mTOR
phosphorylation was not increased in the healthy controls
after the soy meal whereas its downstream target p70S6K
was increased; however, the Ser2448 site on mTOR is
actually an inhibitory site which is phosphorylated by
p70S6K as a negative feedback mechanism [44]. This
suggests that prior to the first post meal muscle biopsy
(2 h) there may have been transient activation of the
mTOR complex as well as p70S6K which was diminished
by the time of sampling in the MetS group.
There have been a number of studies which have
looked at the effects of different proteins on muscle
anabolism however; very little research has addressed
the anabolic potential of different mixed meals more
closely associated with those consumed in everyday
life. A fundamental characteristic of the test meals
used in the present study was a large fat content (54 g).
Previous research indicates that a high fat diet leads to
oversaturation of the oxidative capacity of mitochondria
in muscle [45]. It is unclear if the differences in mTOR
and S6 activation in the present study are simply a result
of different protein sources [18] and leucine content or if
there is an interaction between the fat or carbohydrate
and protein source.
Although this study measured anabolic signalling
throughout the mTOR pathway which controls the initi-
ation of protein translation and thus protein synthesis,
acute anabolic signalling measurements do not always
perfectly line up with measurements of MPS or long
term phenotypic change [46,47]. The measurement of
anabolic signalling provides a ‘snapshot’ of the state of
protein translation within the muscle; because measure-
ments were made only 2 and 4 hours after meal con-
sumption it is possible that activation prior to the first
measurement or between the measurements could have
been missed. Future work should directly measure MPS
over time to provide an average MPS in the postprandial
period.
There are many conflicting reports in the literature
concerning anabolic resistance of protein synthesis and
anabolic signalling deficits in ageing; even less is known
about anabolic resistance or signalling deficits in middle
aged men with obesity and metabolic syndrome. We
report that MetS is associated with impaired down-
stream signalling in the mTOR pathway in response to
two different high protein mixed meals. Secondarily, we
report that other mTOR pathway targets are activated to agreater degree following dairy mixed consumption com-
pared with a soy based meal matched for protein. The pri-
mary novel aspect of this study was the ingestion of a
complete breakfast consisting of whole foods rather than
an isolated liquid protein supplement. Future work should
look to use measurements of muscle protein synthesis to
directly assess differences in anabolic sensitivity in sub-
jects with MetS using mixed meals rather than amino acid
infusions and clamp methodology.
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